Consolidated Statement Of Cash Flows

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7256194

Concept 2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
3,191,000,000 JPY
6,192,000,000 JPY
9,862,000,000 JPY
2,467,000,000 JPY
Depreciation
2,247,000,000 JPY
2,662,000,000 JPY
Impairment losses
300,000,000 JPY
JPY
Interest and dividend income
-293,000,000 JPY
-335,000,000 JPY
Interest expenses
51,000,000 JPY
40,000,000 JPY
Foreign exchange losses (gains)
97,000,000 JPY
15,000,000 JPY
Share of loss (profit) of entities accounted for using equity method
53,000,000 JPY
41,000,000 JPY
Decrease (increase) in trade receivables
1,203,000,000 JPY
-370,000,000 JPY
Subtotal
6,183,000,000 JPY
2,724,000,000 JPY
Decrease (increase) in inventories
-2,675,000,000 JPY
-2,713,000,000 JPY
Income taxes paid
-4,026,000,000 JPY
-1,611,000,000 JPY
Net cash provided by (used in) operating activities
2,485,000,000 JPY
1,486,000,000 JPY
Increase (decrease) in trade payables
339,000,000 JPY
1,494,000,000 JPY
Other, net
-180,000,000 JPY
626,000,000 JPY
Interest and dividends received
379,000,000 JPY
414,000,000 JPY
Interest paid
-51,000,000 JPY
-41,000,000 JPY
Cash flows from investing activities
Purchase of securities
JPY
-500,000,000 JPY
Purchase of property, plant and equipment
-2,960,000,000 JPY
-1,320,000,000 JPY
Proceeds from sale of property, plant and equipment
0 JPY
1,000,000 JPY
Net cash provided by (used in) investing activities
-6,124,000,000 JPY
1,706,000,000 JPY
Purchase of investment securities
JPY
-352,000,000 JPY
Proceeds from sale of investment securities
252,000,000 JPY
4,230,000,000 JPY
Purchase of shares of subsidiaries resulting in change in scope of consolidation
-2,189,000,000 JPY
JPY
Other, net
-1,125,000,000 JPY
845,000,000 JPY
Cash flows from financing activities
Dividends paid
-1,275,000,000 JPY
-792,000,000 JPY
Proceeds from long-term borrowings
3,000,000,000 JPY
JPY
Repayments of long-term borrowings
-4,680,000,000 JPY
-3,138,000,000 JPY
Net cash provided by (used in) financing activities
-2,956,000,000 JPY
-3,943,000,000 JPY
Other, net
JPY
-22,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
-97,000,000 JPY
-15,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-6,692,000,000 JPY
-766,000,000 JPY
Cash and cash equivalents
10,603,000,000 JPY
16,738,000,000 JPY
17,505,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.